Complement genetics and susceptibility to inflammatory disease. Lessons from genotype-phenotype correlations

Immunobiology

Volumn 221, Issue 6, 2016, Pages 709-714

  de Córdoba, Santiago Rodríguez ^a  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

C3; CFHRs; Complement; Disease susceptibility; Factor H; Factor H related proteins

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C3; COMPLEMENT FACTOR H; COMPLEMENT FACTOR H RELATED PROTEIN; PLASMA PROTEIN; UNCLASSIFIED DRUG;

AGE RELATED MACULAR DEGENERATION; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT DEFICIENCY; COMPLEMENT DISORDER; ENVIRONMENTAL FACTOR; GAIN OF FUNCTION MUTATION; GENE DELETION; GENE MUTATION; GENE REARRANGEMENT; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GLOMERULOPATHY; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPOCOMPLEMENTEMIA; IMMUNOGENETICS; INFLAMMATORY DISEASE; LOSS OF FUNCTION MUTATION; MEDICAL RESEARCH; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TISSUE INJURY; ANIMAL; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; INFLAMMATION; PHENOTYPE;

ANIMALS; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFLAMMATION; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 84973255900     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2015.05.015     Document Type: Article

References (84)

1. Abarrategui-Garrido C., Martínez-Barricarte R., López-Trascasa M., et al. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome. Blood 2009, 114:4261-4271.
2. Athanasiou Y., Voskarides K., Gale D.P., et al. Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees. Clin. J. Am. Soc. Nephrol. 2011, 6:1436-1446.
3. Blaum B.S., Hannan J.P., Herbert A.P., et al. Structural basis for sialic acid-mediated self-recognition by complement factor H. Nat. Chem. Biol. 2015, 11:77-82.
4. Caesar J.J.E., Lavender H., Ward P.N., et al. Competition between antagonistic complement factors for a single protein on N. meningitidis rules disease susceptibility. eLife 2014, 3:e04008.
5. Caprioli J., Castelletti F., Bucchioni S., et al. Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease. Hum. Mol. Genet. 2003, 12:3385-3395.
6. Chen Q., Wiesener M., Eberhardt H.U., et al. Complement factor H-related hybrid protein deregulates complement in dense deposit disease. J. Clin. Investig. 2014, 124:145-155.
7. Clark S.J., Higman V.A., Mulloy B., et al. His-384 allotypic variant of factor H associated with age-related macular degeneration has different heparin binding properties from the non-disease-associated form. J. Biol. Chem. 2006, 281:24713-24720.
8. Clark S.J., Perveen R., Hakobyan S., et al. Impaired binding of the age-related macular degeneration-associated complement factor H 402H allotype to Bruch's membrane in human retina. J. Biol. Chem. 2010, 285:30192-30202.
9. Clark S.J., Schmidt C.Q., White A.M., et al. Identification of factor H-like protein 1 as the predominant complement regulator in Bruch's membrane: implications for age-related macular degeneration. J. Immunol. 2014, 193:4962-4970.
10. de Cordoba S.R., Tortajada A., Harris C.L., et al. Complement dysregulation and disease: from genes and proteins to diagnostics and drugs. Immunobiology 2012, 217:1034-1046.
11. Dragon-Durey M.-A., Frémeaux-Bacchi V., Loirat C., et al. Heterozygous and homozygous factor H deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases. J. Am. Soc. Nephrol. 2004, 15:787-795.
12. Edwards A.O., Ritter R., Abel K.J., et al. Complement factor H polymorphism and age-related macular degeneration. Science 2005, 308:421-424.
13. Esparza-Gordillo J., Goicoechea de Jorge E., Buil A., et al. Predisposition to atypical hemolytic uremic syndrome involves the concurrence of different susceptibility alleles in the regulators of complement activation gene cluster in 1q32. Hum. Mol. Genet. 2005, 14:703-712.
14. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 1991, 11:81-128.
15. Ferreira V.P., Herbert A.P., Cortés C., et al. The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome. J. Immunol. 2009, 182:7009-7018.
16. Francis N.J., McNicholas B., Awan A., et al. A novel hybrid CFH/CFHR3 gene generated by a microhomology-mediated deletion in familial atypical hemolytic uremic syndrome. Blood 2012, 119:591-601.
17. Fremeaux-Bacchi V., Fakhouri F., Garnier A., et al. Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. Clin. J. Am. Soc. Nephrol. 2013, 8:554-562.
18. Frémeaux-Bacchi V., Miller E.C., Liszewski M.K., et al. Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome. Blood 2008, 112:4948-4952.
19. Gale D.P., Pickering M.C. Regulating complement in the kidney: insights from CFHR5 nephropathy. Dis. Model. Mech. 2011, 4:721-726.
20. Gale D.P., Goicoechea de Jorge E., Cook H.T., et al. Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis. Lancet 2010, 376:794-801.
21. Gharavi A.G., Kiryluk K., Choi M., et al. Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat. Genet. 2011, 43:321-327.
22. Goicoechea de Jorge E., Caesar J.J.E., Malik T.H., et al. Dimerization of complement factor H-related proteins modulates complement activation in vivo. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:4685-4690.
23. Gorin M.B. Genetic insights into age-related macular degeneration: controversies addressing risk, causality, and therapeutics. Mol. Aspects Med. 2012, 33:467-486.
24. Hageman G.S., Anderson D.H., Johnson L.V., et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:7227-7232.
25. Hakobyan S., Tortajada A., Harris C.L., et al. Variant-specific quantification of factor H in plasma identifies null alleles associated with atypical hemolytic uremic syndrome. Kidney Int. 2010, 78:782-788.
26. Heinen S., Sanchez-Corral P., Jackson M.S., et al. De novo gene conversion in the RCA gene cluster (1q32) causes mutations in complement factor H associated with atypical hemolytic uremic syndrome. Hum. Mutat. 2006, 27:292-293.
27. Høgåsen K., Jansen J.H., Mollnes T.E., et al. Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency. J. Clin. Investig. 1995, 95:1054-1061.
28. Haines J.L., Hauser M.A., Schmidt S., et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 2005, 308:419-421.
29. Holers V.M. The spectrum of complement alternative pathway-mediated diseases. Immunol. Rev. 2008, 223:300-316.
30. Holmes L.V., Strain L., Staniforth S.J., et al. Determining the Population Frequency of the CFHR3/CFHR1 Deletion at 1q32. PLOS ONE 2013, 8:e60352.
31. Hughes A.E., Orr N., Esfandiary H., et al. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat. Genet. 2006, 38:1173-1177.
32. Józsi M., Zipfel P.F. Factor H family proteins and human diseases. Trends Immunol. 2008, 29:380-387.
33. Józsi M., Tortajada A., Uzonyi B., et al. Factor H-related proteins determine complement-activating surfaces. Trends Immunol. 2015, 10.1016/j.it.2015.04.008.
34. Kajander T., Lehtinen M.J., Hyvärinen S., et al. Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:2897-2902.
35. Klein R.J., Zeiss C., Chew E.Y., et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308:385-389.
36. Landau D., Shalev H., Levy-Finer G., et al. Familial hemolytic uremic syndrome associated with complement factor H deficiency. J. Pediatr. 2001, 138:412-417.
37. Levy M., Halbwachs-Mecarelli L., Gubler M-C., et al. H deficiency in two brothers with atypical dense intramembranous deposit disease. Kidney Int. 1986, 30:949-956.
38. Licht C., Heinen S., Jozsi M., et al. Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II). Kidney Int. 2006, 70:42-50.
39. Malik T.H., Lavin P.J., Goicoechea de Jorge E., et al. A hybrid CFHR3-1 gene causes familial C3 glomerulopathy. J. Am. Soc. Nephrol. 2012, 23:1155-1160.
40. Manuelian T., Hellwage J., Meri S., et al. Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome. J. Clin. Investig. 2003, 111:1181-1190.
41. Martinez-Barricarte R., Pianetti G., Gautard R., et al. The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndrome. J. Am. Soc. Nephrol. 2008, 19:639-646.
42. Martínez-Barricarte R., Heurich M., Valdes-Cañedo F., et al. Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation. J. Clin. Investig. 2010, 120:3702-3712.
43. Martínez-Barricarte R., Recalde S., Fernández-Robredo P., et al. Relevance of complement factor H-related 1 (CFHR1) genotypes in age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2012, 53:1087-1094.
44. Martínez-Barricarte R., Heurich M., López-Perrote A., et al. The molecular and structural bases for the association of three mutations in the complement component C3 with atypical hemolytic uremic síndrome. Mol. Immunol. 2015, 66:263-273.
45. Matsumoto T., Fan X., Ishikawa E., et al. Analysis of patients with atypical hemolytic uremic syndrome treated at the Mie University Hospital: concentration of C3 p.I1157T mutation. Int. J. Hematol. 2014, 100:437-442.
46. Montes T., Goicoechea de Jorge E., Ramos R., et al. Genetic deficiency of complement factor H in a patient with age-related macular degeneration and membranoproliferative glomerulonephritis. Mol. Immunol. 2008, 45:2897-2904.
47. Morgan H.P., Schmidt C.Q., Guariento M., et al. Structural basis for engagement by complement factor H of C3b on a self surface. Nat. Struct. Mol. Biol. 2011, 18:463-470.
48. Morgan H.P., Mertens H.D.T., Guariento M., et al. Structural analysis of the C-terminal region (modules 18-20) of complement regulator factor H (FH). PLoS ONE 2012, 7:e32187.
49. Närkiö-Mäkelä M., Hellwage J., Tahkokallio O., et al. Complement-regulator factor H and related proteins in otitis media with effusion. Clin. Immunol. 2001, 100:118-126.
50. Noris M., Remuzzi G. Atypical hemolytic-uremic syndrome. N. Engl. J. Med. 2009, 361:1676-1687.
51. Noris M., Caprioli J., Bresin E., et al. Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype. Clin. J. Am. Soc. Nephrol. 2010, 5:1844-1859.
52. Ohali M., Shalev H., Schlesinger M., et al. Hypocomplementemic autosomal recessive hemolytic uremic syndrome with decreased factor H. Pediatr. Nephrol. 1998, 12:619-624.
53. Pérez-Caballero D., González-Rubio C., Gallardo M.E., et al. Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome. Am. J. Hum. Genet. 2001, 68:478-484.
54. Pickering M.C., Cook H.T. Translational mini-review series on complement factor H: renal diseases associated with complement factor H: novel insights from humans and animals. Clin. Exp. Immunol. 2008, 151:210-230.
55. Pickering M.C., Cook H.T., Warren J., et al. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat. Genet. 2002, 31:424-428.
56. Pickering M.C., Goicoechea de Jorge E., Martínez-Barricarte R., et al. Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains. J. Exp. Med. 2007, 204:1249-1256.
57. Prosser B.E., Johnson S., Roversi P., et al. Structural basis for complement factor H linked age-related macular degeneration. J. Exp. Med. 2007, 204:2277-2283.
58. Raychaudhuri S., Iartchouk O., Chin K., et al. A rare penetrant mutation in CFH confers high risk of age-related macular degeneration. Nat. Genet. 2011, 43:1232-1236.
59. Ricklin D., Lambris J.D. Complement in immune and inflammatory disorders: pathophysiological mechanisms. J. Immunol. 2013, 190:3831-3838.
60. Ricklin D., Hajishengallis G., Yang K., et al. Complement - a key system for immune surveillance and homeostasis. Nat. Immunol. 2010, 11:785-797.
61. Rodríguez de Córdoba S., Esparza-Gordillo J., Goicoechea de Jorge E., et al. The human complement factor H: functional roles, genetic variations and disease associations. Mol. Immunol. 2004, 41:355-367.
62. Román-Ortiz E., Mendizabal Oteiza S., Pinto S., et al. Eculizumab long-term therapy for pediatric renal transplant in aHUS with CFH/CFHR1 hybrid gene. Pediatr. Nephrol. 2014, 29:149-153.
63. Rose K.L., Paixao-Cavalcante D., Fish J., et al. Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice. J. Clin. Investig. 2008, 118:608-618.
64. Rosenblad T., Rebetz J., Johansson M., et al. Eculizumab treatment for rescue of renal function in IgA nephropathy. Pediatr. Nephrol. 2014, 29:2225-2228.
65. Roumenina L.T., Frimat M., Miller E.C., et al. A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function. Blood 2012, 119:4182-4191.
66. Sánchez-Corral P., Pérez-Caballero D., Huarte O., et al. Structural and functional characterization of factor H mutations associated with atypical hemolytic uremic syndrome. Am. J. Hum. Genet. 2002, 71:1285-1295.
67. Sánchez-Corral P., González-Rubio C., Rodríguez de Córdoba S., et al. Functional analysis in serum from atypical Hemolytic Uremic Syndrome patients reveals impaired protection of host cells associated with mutations in factor H. Mol. Immunol. 2004, 41:81-84.
68. Sansbury F.H., Cordell H.J., Bingham C., et al. Factors determining penetrance in familial atypical haemolytic uraemic syndrome. J. Med. Genet. 2014, 51:756-764.
69. Schneider M.C., Prosser B.E., Caesar J.J.E., et al. Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates. Nature 2009, 458:890-893.
70. Schramm E.C., Roumenina L.T., Rybkine T., et al. Functional mapping of the interactions between complement C3 and regulatory proteins using atypical hemolytic uremic syndrome-associated mutations. Blood 2015, pii:blood-2014-10-609073. [Epub ahead of print].
71. Servais A., Frémeaux-Bacchi V., Lequintrec M., et al. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome. J. Med. Genet. 2007, 44:193-199.
72. Skerka C., Zipfel P.F. Complement factor H related proteins in immune diseases. Vaccine 2008, 26(Supplement 8):I9-I14.
73. Smith R.J.H., Alexander J., Barlow P.N., et al. New approaches to the treatment of dense deposit disease. J. Am. Soc. Nephrol. 2007, 18:2447-2456.
74. Smith R.J.H., Harris C.L., Pickering M.C. Dense deposit disease. Mol. Immunol. 2011, 48:1604-1610.
75. Tortajada A., Yébenes H., Abarrategui-Garrido C., et al. C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation. J. Clin. Investig. 2013, 123:2434-2446.
76. Valoti E., Alberti M., Tortajada A., et al. A novel atypical hemolytic uremic syndrome-associated hybrid CFHR1/CFH gene encoding a fusion protein that antagonizes factor H-dependent complement regulation. J. Am. Soc. Nephrol. 2015, 26:209-219.
77. Venables J.P., Strain L., Routledge D., et al. Atypical haemolytic uremic syndrome associated with a hybrid complement gene. PLoS Med. 2006, 3:e431.
78. Volokhina E., Westra D., Xue X., et al. Novel C3 mutation p.Lys65Gln in aHUS affects complement factor H binding. Pediatr. Nephrol. 2012, 27:1519-1524.
79. Weismann D., Hartvigsen K., Lauer N., et al. Complement factor H binds malondialdehyde epitopes and protects from oxidative stress. Nature 2011, 478:76-81.
80. Wilson V., Darlay R., Wong W., et al. Genotype/phenotype correlations in complement factor H deficiency arising from uniparental isodisomy. Am. J. Kidney Dis. 2013, 62:978-983.
81. Wyatt R.J., Julian B.A. IgA Nephropathy. N. Engl. J. Med. 2013, 368:2402-2414.
82. Zhang Y., Xiao X., Garcia-Fernandez J., et al. A novel fusion gene CHFR5-CFHR2 causes C3 glomerulonephritis. Mol. Immunol. 2013, 56:297.
83. Zhao J., Wu H., Khosravi M., et al. Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility. PLoS Genet. 2011, 7:e1002079.
84. Zipfel P.F. Complement and immune defense: from innate immunity to human diseases. Immunol. Lett. 2009, 126:1-7.